Clinical outcomes of glaucoma treatment over a patient lifetime: a Markov model (letter).
Kymes
Steven
S
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001766:Blindness / Q000503:physiopathology; D005902:Glaucoma, Open-Angle / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects / Q000502:physiology*; D053685:Laser Therapy; D008390:Markov Chains; D008954:Models, Biological; D009010:Monte Carlo Method; D009798:Ocular Hypertension / Q000503:physiopathology / Q000628:therapy; D017063:Outcome Assessment, Health Care; D019057:Quality-Adjusted Life Years; D012607:Scotoma / Q000503:physiopathology; D012680:Sensitivity and Specificity; D014130:Trabeculectomy / Q000379:methods; D014794:Visual Fields
D000959:Antihypertensive Agents